Will direct-to-physician pharma marketing be the same after Purdue Pharma? – Econsultancy

On Sunday night, embattled pharma firm Purdue Pharma filed for bankruptcy. The maker of the painkiller OxyContin has been facing lawsuits from an estimated 2,600 government entities and other groups and had struck a tentative deal to settle many of them for somewhere between $10bn to $12bn. The lawsuits allege that Purdue was largely responsible […]

Will direct-to-physician pharma marketing be the same after Purdue Pharma? – Econsultancy Read More »